Chung-Che Wu

Challenges and Opportunities of γδ T Cell-Based Immunotherapy for Glioblastoma

Glioblastoma remains the most lethal primary malignancy of the central nervous system, and the modest gains achieved with maximal surgery, radiotherapy and temozolomide have not been matched by the immune checkpoint inhibitors and antigen-specific vaccines that reshaped the treatment of many extracranial cancers. The r...